<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2021" title="RXN-12124" organism="TAX-3702" source="PlantCyc">
  <Description>Single reaction view for RXN-12124: RXN-12124</Description>
  <Authors>
    <Author name="BioCyc" />
  </Authors>
  <Comment source="Automated Conversion">This GPML file was automatically generated from BioCyc single reaction data.</Comment>
  <Property key="UniqueID" value="RXN-12124" />
  <Graphics boardWidth="1200" boardHeight="800" />
  <DataNodes>
    <DataNode elementId="AT4G24220" textLabel="VEP1" type="GeneProduct">
      <Xref identifier="AT4G24220" dataSource="TAIR" />
      <Graphics centerX="100" centerY="50" width="90.0" height="25.0" textColor="000000" fontName="Arial" fontWeight="Normal" fontStyle="Normal" fontDecoration="Normal" fontStrikethru="Normal" fontSize="12" hAlign="Center" vAlign="Middle" borderColor="000000" borderStyle="Solid" borderWidth="1.0" fillColor="FFFFFF" shapeType="Rectangle" />
      <Property key="UniqueID" value="AT4G24220" />
      <Property key="Synonym_1" value="5&amp;beta;-StR" />
      <Property key="Product" value="AT4G24220-MONOMER" />
      <Property key="GeneType" value="Genes" />
    </DataNode>
    <DataNode elementId="AT4G24220-MONOMER" textLabel="enone reductase" type="Protein">
      <Xref identifier="A8MRU3" dataSource="uniprot" />
      <Graphics centerX="150" centerY="215" width="90.0" height="25.0" textColor="000000" fontName="Arial" fontWeight="Normal" fontStyle="Normal" fontDecoration="Normal" fontStrikethru="Normal" fontSize="12" hAlign="Center" vAlign="Middle" borderColor="000000" borderStyle="Solid" borderWidth="1.0" fillColor="FFFFFF" shapeType="Rectangle" />
      <Comment source="AU4FS-1, THE-ARABIDOPSIS-INFORMATION-RESOURCE, dreher">VEP1 is a member of the short-chain dehydrogenase / reductase family of enzymes. A purified recombinant version of the protein can catalyze the stereo-specific reduction of |FRAME: PROGESTERONE progesterone| |CITS: [19166903]|, though this is not expected to be a substrate for the enzyme &lt;i&gt;in vivo&lt;/i&gt; in |FRAME: ORG-5993 &lt;i&gt;Arabidopsis thaliana&lt;/i&gt; col| plants. It can also act on several additional &amp;Delta;-4,5-steroids that have a 3-oxo group, including |FRAME: ANDROST4ENE androst-4-ene-3,17-dione|, 21-acetyl cortexone, |FRAME: CORTISONE cortisone| and canarigenone |CITS: [19166903]|. Furthermore, it is active against a number of smaller molecules including |FRAME: CPD-282 cyclohex-2-enone|, but-1-en-3-one, and ethyl propenoate. This suggests that an activated carbon-carbon double bond is an important determinant of VEP1 substrate preference and that VPE1 may play a broader role as an enone reductase |CITS: [20598327]|. To date, the biological substrates of VEP1 are not known, though there is some speculation that VEP1 may participate in the formation of 5&amp;beta;-configured phytoecdysteroids because these compounds have been found in Arabidopsis |CITS: [19166903]|. Interestingly, mutants with defects in VEP1 expression have abnormal leaf venation patterns |CITS: [11917087]|. Based on gel filtration assays and native PAGE, VEP1 had an apparent molecular weight of 110 kD, suggesting that it forms a homodimer. However, this has not been confirmed experimentally |CITS: [19166903]|.</Comment>
      <Property key="UniqueID" value="AT4G24220-MONOMER" />
      <Property key="AlternativeId_Araport" value="AT4G24220.1" />
      <Property key="AlternativeId_Pid" value="AAL32529.1" />
      <Property key="AlternativeId_Uniprot" value="A8MRU3" />
      <Property key="Synonym_1" value="progesterone-5&amp;beta;-reductase-like protein" />
      <Property key="Synonym_2" value="substrate-promiscuous enone reductase" />
      <Property key="IsoelectricPoint" value="5.5" />
      <Property key="Gene" value="AT4G24220" />
      <Property key="Catalyzes" value="RXN-18643, RXN-18927, RXN-18683" />
      <Property key="CatalyzesCount" value="3" />
      <Property key="ProteinType" value="Polypeptides" />
      <Property key="Species" value="ORG-5993" />
      <CitationRef elementRef="citation_cit_19166903" />
      <CitationRef elementRef="citation_cit_20598327" />
      <CitationRef elementRef="citation_cit_11917087" />
    </DataNode>
    <DataNode elementId="ANDROST4ENE" textLabel="androstenedione" type="Metabolite">
      <Xref identifier="AEMFNILZOJDQLW-QAGGRKNESA-N" dataSource="InChIKey" />
      <Graphics centerX="200" centerY="400" width="90.0" height="25.0" textColor="3955e7" fontName="Arial" fontWeight="Normal" fontStyle="Normal" fontDecoration="Normal" fontStrikethru="Normal" fontSize="12" hAlign="Center" vAlign="Middle" borderColor="3955e7" borderStyle="Solid" borderWidth="1.0" fillColor="FFFFFF" shapeType="Rectangle" />
      <Comment>|FRAME: ANDROST4ENE &quot;Androst-4-ene-3,17-dione&quot;| (androstenedione) is a key intermediate of microbial steroid metabolism. It is a naturally occurring steroid hormone produced in the gonad or ovary, and an immediate precursor of |FRAME: TESTOSTERONE| in males and |FRAME: CPD-352| and |FRAME: ESTRONE| in females |CITS: [18329874]|. The compound was first isolated in 1931 from a male policeman&apos;s urine and named androsterone (andro = male, ster = sterol, one = ketone) |CITS: [Butenandt34]|. The chemical structure of androsterone was reported soon after |CITS: [Ruzicka34]|.</Comment>
      <Property key="UniqueID" value="ANDROST4ENE" />
      <Property key="AlternativeId_Zinc" value="ZINC000004428526" />
      <Property key="AlternativeId_ReactomeCpd" value="193079" />
      <Property key="AlternativeId_Seed" value="cpd00237" />
      <Property key="AlternativeId_Metanetx" value="MNXM239" />
      <Property key="AlternativeId_Refmet" value="Androstenedione" />
      <Property key="AlternativeId_Pubchem" value="6128" />
      <Property key="AlternativeId_Metabolights" value="MTBLC16422" />
      <Property key="AlternativeId_Hmdb" value="HMDB00053" />
      <Property key="AlternativeId_Drugbank" value="DB01536" />
      <Property key="AlternativeId_Chebi" value="16422" />
      <Property key="AlternativeId_LigandCpd" value="C00280" />
      <Property key="AlternativeId_Cas" value="63-05-8" />
      <Property key="AlternativeId_Nci" value="9563" />
      <Property key="Synonym_1" value="4-androstene-3,17-dione" />
      <Property key="Synonym_2" value="androst-4-ene-3,17-dione" />
      <Property key="MolecularWeight" value="286.413" />
      <Property key="MonoisotopicWeight" value="286.1932800788" />
      <Property key="ChemicalFormula" value="(C 19)(H 26)(O 2)" />
      <Property key="InChI" value="InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1" />
      <Property key="InChIKey" value="InChIKey=AEMFNILZOJDQLW-QAGGRKNESA-N" />
      <Property key="SMILES" value="C[C@@]34(CCC(=O)\C=C(CC[C@@H]1([C@H](CC[C@]2(C)(C(CC[C@@H]12)=O))3))/4)" />
      <Property key="GibbsFreeEnergy" value="248.61913" />
      <Property key="CompoundType" value="3-Oxo-Delta-4-Steroids, Androgens" />
      <CitationRef elementRef="citation_cit_18329874" />
    </DataNode>
    <DataNode elementId="CPD-342" textLabel="5Î±-androstanedione" type="Metabolite">
      <Xref identifier="RAJWOBJTTGJROA-WZNAKSSCSA-N" dataSource="InChIKey" />
      <Graphics centerX="350" centerY="400" width="90.0" height="25.0" textColor="3955e7" fontName="Arial" fontWeight="Normal" fontStyle="Normal" fontDecoration="Normal" fontStrikethru="Normal" fontSize="12" hAlign="Center" vAlign="Middle" borderColor="3955e7" borderStyle="Solid" borderWidth="1.0" fillColor="FFFFFF" shapeType="Rectangle" />
      <Property key="UniqueID" value="CPD-342" />
      <Property key="AlternativeId_Zinc" value="ZINC000003881403" />
      <Property key="AlternativeId_Seed" value="cpd00511" />
      <Property key="AlternativeId_Metanetx" value="MNXM2200" />
      <Property key="AlternativeId_Refmet" value="Androstanedione" />
      <Property key="AlternativeId_Pubchem" value="222865" />
      <Property key="AlternativeId_Metabolights" value="MTBLC15994" />
      <Property key="AlternativeId_Hmdb" value="HMDB00899" />
      <Property key="AlternativeId_Drugbank" value="DB01561" />
      <Property key="AlternativeId_Chemspider" value="388422" />
      <Property key="AlternativeId_Chebi" value="15994" />
      <Property key="AlternativeId_LigandCpd" value="C00674" />
      <Property key="AlternativeId_Cas" value="846-46-8" />
      <Property key="Synonym_1" value="dihydroandrostenedione" />
      <Property key="Synonym_2" value="androstane-3,17-dione" />
      <Property key="Synonym_3" value="5&amp;alpha;-androstane-3,17-dione" />
      <Property key="MolecularWeight" value="288.429" />
      <Property key="MonoisotopicWeight" value="288.208930143" />
      <Property key="ChemicalFormula" value="(C 19)(H 28)(O 2)" />
      <Property key="InChI" value="InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-16H,3-11H2,1-2H3/t12-,14-,15-,16-,18-,19-/m0/s1" />
      <Property key="InChIKey" value="InChIKey=RAJWOBJTTGJROA-WZNAKSSCSA-N" />
      <Property key="SMILES" value="C[C@@]14(CCC(=O)C[C@H](CC[C@@H]2([C@@H]1CC[C@]3(C)(C(=O)CC[C@@H]23)))4)" />
      <Property key="GibbsFreeEnergy" value="251.33138" />
      <Property key="CompoundType" value="3-Oxo-5-Alpha-Steroids" />
    </DataNode>
    <DataNode elementId="Acceptor" textLabel="an oxidized electron carrier" type="Metabolite">
      <Xref identifier="15339" dataSource="ChEBI" />
      <Graphics centerX="500" centerY="400" width="90.0" height="25.0" textColor="3955e7" fontName="Arial" fontWeight="Normal" fontStyle="Normal" fontDecoration="Normal" fontStrikethru="Normal" fontSize="12" hAlign="Center" vAlign="Middle" borderColor="3955e7" borderStyle="Solid" borderWidth="1.0" fillColor="FFFFFF" shapeType="Rectangle" />
      <Comment>In general, an electron carrier is a chemical entity that can accept or donate electrons from/to another chemical entity. When accepting electrons, it acts as an &quot;electron acceptor&quot;. By accepting the electrons, the acceptor is reduced, and thus prior to receiving the electrons the entity is called &quot;an oxidized electron acceptor&quot; and after receiving them it is called &quot;a reduced electron acceptor&quot;. Many reduced electron acceptors are able to transfer the electrons to other molecules, becoming oxidized in the process. Thus the distinction between an electron acceptor and an electron donor is often not determined by the actual chemical entity, but by the role it plays in a particular reaction. However, some acceptors in biological reactions only accept electrons and do not transfer them further. Those are often known as &quot;terminal electron acceptors&quot;. While in general every chemical reaction in which electrons are transferred includes an electron donor and an electron acceptor, several molecules are commonly used in metabolism solely for the purpose of electron transfer, and are referred to in biology as electron carriers. Different biological electron carriers differ in the number of electrons that they transfer and in their electron affinity. Some of the common biological electron carriers transfer only a single electron (e.g. |FRAME: Cytochromes cytochromes|, |FRAME: Blue-Copper-Proteins &quot;blue copper proteins&quot;|, and some |FRAME: Ferredoxins ferredoxins|), some transfer two electrons (e.g. some |FRAME: Ferredoxins ferredoxins|), some transfer a hydride ion ( e.g. |FRAME: NAD| and |FRAME: NADP|), and some transfer two electrons and two protons (|FRAME: ETR-Quinones quinones|, |FRAME: FAD| and |FRAME: FMN|). In addition, a number of inorganic small molecules (e.g. oxygen, nitrate, iron (III), manganese (IV), sulfate) are often used as terminal electron acceptors. In many cases, purified enzymes can act &lt;i&gt;in vitro&lt;/i&gt; using an artificial electron carrier, and their &lt;i&gt;in vivo&lt;/i&gt; electron carrier is not known. This class of &quot;unknown electron carriers&quot; is used to describe such reactions, which are incompletely characterized.</Comment>
      <Property key="UniqueID" value="Acceptor" />
      <Property key="AlternativeId_ReactomeCpd" value="5359011" />
      <Property key="AlternativeId_Metanetx" value="MNXM8975" />
      <Property key="AlternativeId_LigandCpd" value="C00028" />
      <Property key="AlternativeId_Chebi" value="15339" />
      <Property key="Synonym_1" value="A" />
      <Property key="Synonym_2" value="an oxidized unknown electron donor" />
      <Property key="Synonym_3" value="an oxidized unknown electron acceptor" />
      <Property key="CompoundType" value="Hydride-Acceptors" />
      <Property key="AbbreviatedName" value="A" />
    </DataNode>
    <DataNode elementId="Donor-H2" textLabel="a reduced two electron carrier" type="Metabolite">
      <Xref identifier="17499" dataSource="ChEBI" />
      <Graphics centerX="200" centerY="500" width="90.0" height="25.0" textColor="3955e7" fontName="Arial" fontWeight="Normal" fontStyle="Normal" fontDecoration="Normal" fontStrikethru="Normal" fontSize="12" hAlign="Center" vAlign="Middle" borderColor="3955e7" borderStyle="Solid" borderWidth="1.0" fillColor="FFFFFF" shapeType="Rectangle" />
      <Comment>In general, an electron carrier is a chemical entity that can accept or donate electrons from/to another chemical entity. When accepting electrons, it acts as an &quot;electron acceptor&quot;. By accepting the electrons, the acceptor is reduced, and thus prior to receiving the electrons the entity is called &quot;an oxidized electron acceptor&quot; and after receiving them it is called &quot;a reduced electron acceptor&quot;. Many reduced electron acceptors are able to transfer the electrons to other molecules, becoming oxidized in the process. Thus the distinction between an electron acceptor and an electron donor is often not determined by the actual chemical entity, but by the role it plays in a particular reaction. However, some acceptors in biological reactions only accept electrons and do not transfer them further. Those are often known as &quot;terminal electron acceptors&quot;. While in general every chemical reaction in which electrons are transferred includes an electron donor and an electron acceptor, several molecules are commonly used in metabolism solely for the purpose of electron transfer, and are referred to in biology as electron carriers. Different biological electron carriers differ in the number of electrons that they transfer and in their electron affinity. Some of the common biological electron carriers transfer only a single electron (e.g. |FRAME: Cytochromes cytochromes|, |FRAME: Blue-Copper-Proteins &quot;blue copper proteins&quot;|, and some |FRAME: Ferredoxins ferredoxins|), some transfer two electrons (e.g. some |FRAME: Ferredoxins ferredoxins|), some transfer a hydride ion ( e.g. |FRAME: NAD| and |FRAME: NADP|), and some transfer two electrons and two protons (|FRAME: ETR-Quinones quinones|, |FRAME: FAD| and |FRAME: FMN|). In addition, a number of inorganic small molecules (e.g. oxygen, nitrate, iron (III), manganese (IV), sulfate) are often used as terminal electron acceptors. In many cases, purified enzymes can act &lt;i&gt;in vitro&lt;/i&gt; using an artificial electron carrier, and their &lt;i&gt;in vivo&lt;/i&gt; electron carrier is not known. The classes of &quot;unknown electron carriers&quot; are used to describe such reactions, which are incompletely characterized.</Comment>
      <Property key="UniqueID" value="Donor-H2" />
      <Property key="AlternativeId_Seed" value="cpd26978" />
      <Property key="AlternativeId_Metanetx" value="MNXM36" />
      <Property key="AlternativeId_Chebi" value="17499" />
      <Property key="AlternativeId_LigandCpd" value="C00030" />
      <Property key="Synonym_1" value="a reduced unknown two electron donor" />
      <Property key="Synonym_2" value="A(H2)" />
      <Property key="Synonym_3" value="a reduced unknown two electron acceptor" />
      <Property key="SMILES" value="[an oxidized electron carrier]" />
      <Property key="CompoundType" value="Hydride-Acceptors" />
      <Property key="AbbreviatedName" value="A(H2)" />
    </DataNode>
  </DataNodes>
  <Interactions>
    <Interaction elementId="gene_protein_0_0_0">
      <Waypoints>
        <Point elementId="gene_protein_start_0_0_0" x="145.0" y="50" elementRef="AT4G24220" relX="1.0" relY="0.0" />
        <Point elementId="gene_protein_end_0_0_0" arrowHead="TranscriptionTranslation" x="105.0" y="215" elementRef="AT4G24220-MONOMER" relX="-1.0" relY="0.0" />
      </Waypoints>
      <Graphics lineColor="000000" lineStyle="Solid" lineWidth="1.0" connectorType="Straight" />
    </Interaction>
    <Interaction elementId="RXN-12124">
      <Xref identifier="EC-1.3.99.5" dataSource="Enzyme Nomenclature" />
      <Waypoints>
        <Point elementId="RXN-12124_start" x="395.0" y="400" elementRef="CPD-342" relX="1.0" relY="0.0" />
        <Point elementId="RXN-12124_end" arrowHead="Conversion" x="155.0" y="400" elementRef="ANDROST4ENE" relX="-1.0" relY="0.0" />
        <Anchor elementId="RXN-12124_anchor" position="0.5" shapeType="Circle" />
      </Waypoints>
      <Graphics lineColor="000000" lineStyle="Solid" lineWidth="1.0" connectorType="Straight" />
      <Property key="UniqueID" value="RXN-12124" />
      <Property key="EC_Number" value="EC-1.3.99.5" />
      <Property key="Orphan" value=":NO" />
      <Property key="ReactionEquation" value="CPD-342 + Acceptor =&gt; ANDROST4ENE + Donor-H2" />
      <Property key="ReactionDirection" value="LEFT-TO-RIGHT" />
      <Property key="BalanceStatus" value=":BALANCED" />
      <Property key="PhysiologicallyRelevant" value="T" />
      <Property key="EnzymaticReaction" value="ENZRXN-18683" />
      <Property key="SystematicName" value="17&amp;beta;-hydroxysteroid:NADP&lt;small&gt;&lt;sup&gt;+&lt;/sup&gt;&lt;/small&gt; 17-oxidoreductase" />
      <Property key="ReactionTypes" value="Small-Molecule-Reactions, Chemical-Reactions" />
      <CitationRef elementRef="citation_cit_19166903" />
    </Interaction>
    <Interaction elementId="RXN-12124_ENZRXN-18683">
      <Waypoints>
        <Point elementId="RXN-12124_ENZRXN-18683_start" x="150" y="227.5" elementRef="AT4G24220-MONOMER" relX="0.0" relY="1.0" />
        <Point elementId="RXN-12124_ENZRXN-18683_end" arrowHead="Catalysis" x="0" y="0" elementRef="RXN-12124_anchor" relX="0.0" relY="-1.0" />
      </Waypoints>
      <Graphics lineColor="000000" lineStyle="Solid" lineWidth="1.0" connectorType="Straight" />
    </Interaction>
    <Interaction elementId="RXN-12124_anchor_reactant_1">
      <Xref identifier="EC-1.3.99.5" dataSource="Enzyme Nomenclature" />
      <Waypoints>
        <Point elementId="RXN-12124_anchor_reactant_start_1" x="545.0" y="400" elementRef="Acceptor" relX="1.0" relY="0.0" />
        <Point elementId="RXN-12124_anchor_reactant_end_1" x="0" y="0" elementRef="RXN-12124_anchor" relX="0.0" relY="0.0" />
      </Waypoints>
      <Graphics lineColor="000000" lineStyle="Solid" lineWidth="1.0" connectorType="Straight" />
    </Interaction>
    <Interaction elementId="RXN-12124_anchor_product_1">
      <Xref identifier="EC-1.3.99.5" dataSource="Enzyme Nomenclature" />
      <Waypoints>
        <Point elementId="RXN-12124_anchor_product_start_1" x="0" y="0" elementRef="RXN-12124_anchor" relX="0.0" relY="0.0" />
        <Point elementId="RXN-12124_anchor_product_end_1" arrowHead="Conversion" x="155.0" y="500" elementRef="Donor-H2" relX="-1.0" relY="0.0" />
      </Waypoints>
      <Graphics lineColor="000000" lineStyle="Solid" lineWidth="1.0" connectorType="Straight" />
    </Interaction>
  </Interactions>
  <Citations>
    <Citation elementId="citation_cit_18329874">
      <Xref identifier="18329874" dataSource="pubmed" />
    </Citation>
    <Citation elementId="citation_cit_19166903">
      <Xref identifier="19166903" dataSource="pubmed" />
    </Citation>
    <Citation elementId="citation_cit_20598327">
      <Xref identifier="20598327" dataSource="pubmed" />
    </Citation>
    <Citation elementId="citation_cit_11917087">
      <Xref identifier="11917087" dataSource="pubmed" />
    </Citation>
  </Citations>
</Pathway>
